Baidu
map

Lancet:震惊!健美运动员服用禁药后的可怕后果-案例报道

2016-05-13 Mechront MedSci原创

职业运动员使用性能增强药物得到越来越多的关注,这里将给大家带来一个关于业余健美运动员使用禁药后出现可怕后果的案例报道。患者男,21岁,因全身不适就诊。患者低热,在胸部和上背部有大量脓肿和脓疱,伴深溃疡。追问病史后,患者自诉有合成类固醇激素药物滥用史,每周服用两次250 mg庚酸睾丸素和30 mg去氢甲睾酮。患者诊断为:合成类固醇激素诱导的重度聚合型痤疮。治疗:停止合成类固醇激素的使用,使用防腐剂和

职业运动员使用性能增强药物得到越来越多的关注,这里将给大家带来一个关于业余健美运动员使用禁药后出现可怕后果的案例报道。

患者男,21岁,因全身不适就诊。

患者低热,在胸部和上背部有大量脓肿和脓疱,伴深溃疡。




追问病史后,患者自诉有合成类固醇激素药物滥用史,每周服用两次250 mg庚酸睾丸素和30 mg去氢甲睾酮。

患者诊断为:合成类固醇激素诱导的重度聚合型痤疮。

治疗:停止合成类固醇激素的使用,使用消毒剂和抗生素治疗。

患者的皮损很快恢复,但是皮损恢复后的疤痕可能会伴随这名年轻男性的余生。



此外值得一提的是,调查者还发现了患者的其他损害,他的精子浓度和睾丸体积在减少。

原始出处:

Peter A Gerber,Gabriela Kukova,et al.The dire consequences of doping.The Lancet.DOI: http://dx.doi.org/10.1016/S0140-6736(08)61278-7

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1828485, encodeId=28f918284856e, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Fri Mar 03 09:53:00 CST 2017, time=2017-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=106871, encodeId=ef501068e12c, content=深入学习,好文值得点赞!, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7s7ZCKOmmbBTD6nE7gcd5OZpvyGEzkxBP3S275k5ZJVrsPkotZhBglRHM9rKvcj1OgkssqhcnoPw8zIaMZTF8c/0, createdBy=4c441942088, createdName=ylzr123, createdTime=Mon Aug 29 14:21:00 CST 2016, time=2016-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=96914, encodeId=064b96914e6, content=可怕的副作用。但这些都阻止不了他们, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160515/IMG57380B859AD1F1019.jpg, createdBy=2c5c1621956, createdName=jasonuclear, createdTime=Mon Aug 08 15:46:00 CST 2016, time=2016-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1604574, encodeId=8ba116045e4e2, content=<a href='/topic/show?id=88e6941544c' target=_blank style='color:#2F92EE;'>#运动员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94154, encryptionId=88e6941544c, topicName=运动员)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c1419230799, createdName=gujh, createdTime=Sun May 15 03:53:00 CST 2016, time=2016-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=85793, encodeId=692085e931d, content=好可惜缺乏一定的医学常识, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160613/IMG575D9886B86721544.jpg, createdBy=07961686486, createdName=1de4921fm57(暂无匿称), createdTime=Sun May 15 02:11:00 CST 2016, time=2016-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=85682, encodeId=ae01856826c, content=不作死就不会死, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=172d1721528, createdName=QQ6709219e, createdTime=Fri May 13 23:56:00 CST 2016, time=2016-05-13, status=1, ipAttribution=)]
    2017-03-03 howi
  2. [GetPortalCommentsPageByObjectIdResponse(id=1828485, encodeId=28f918284856e, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Fri Mar 03 09:53:00 CST 2017, time=2017-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=106871, encodeId=ef501068e12c, content=深入学习,好文值得点赞!, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7s7ZCKOmmbBTD6nE7gcd5OZpvyGEzkxBP3S275k5ZJVrsPkotZhBglRHM9rKvcj1OgkssqhcnoPw8zIaMZTF8c/0, createdBy=4c441942088, createdName=ylzr123, createdTime=Mon Aug 29 14:21:00 CST 2016, time=2016-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=96914, encodeId=064b96914e6, content=可怕的副作用。但这些都阻止不了他们, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160515/IMG57380B859AD1F1019.jpg, createdBy=2c5c1621956, createdName=jasonuclear, createdTime=Mon Aug 08 15:46:00 CST 2016, time=2016-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1604574, encodeId=8ba116045e4e2, content=<a href='/topic/show?id=88e6941544c' target=_blank style='color:#2F92EE;'>#运动员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94154, encryptionId=88e6941544c, topicName=运动员)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c1419230799, createdName=gujh, createdTime=Sun May 15 03:53:00 CST 2016, time=2016-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=85793, encodeId=692085e931d, content=好可惜缺乏一定的医学常识, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160613/IMG575D9886B86721544.jpg, createdBy=07961686486, createdName=1de4921fm57(暂无匿称), createdTime=Sun May 15 02:11:00 CST 2016, time=2016-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=85682, encodeId=ae01856826c, content=不作死就不会死, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=172d1721528, createdName=QQ6709219e, createdTime=Fri May 13 23:56:00 CST 2016, time=2016-05-13, status=1, ipAttribution=)]
    2016-08-29 ylzr123

    深入学习,好文值得点赞!

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1828485, encodeId=28f918284856e, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Fri Mar 03 09:53:00 CST 2017, time=2017-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=106871, encodeId=ef501068e12c, content=深入学习,好文值得点赞!, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7s7ZCKOmmbBTD6nE7gcd5OZpvyGEzkxBP3S275k5ZJVrsPkotZhBglRHM9rKvcj1OgkssqhcnoPw8zIaMZTF8c/0, createdBy=4c441942088, createdName=ylzr123, createdTime=Mon Aug 29 14:21:00 CST 2016, time=2016-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=96914, encodeId=064b96914e6, content=可怕的副作用。但这些都阻止不了他们, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160515/IMG57380B859AD1F1019.jpg, createdBy=2c5c1621956, createdName=jasonuclear, createdTime=Mon Aug 08 15:46:00 CST 2016, time=2016-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1604574, encodeId=8ba116045e4e2, content=<a href='/topic/show?id=88e6941544c' target=_blank style='color:#2F92EE;'>#运动员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94154, encryptionId=88e6941544c, topicName=运动员)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c1419230799, createdName=gujh, createdTime=Sun May 15 03:53:00 CST 2016, time=2016-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=85793, encodeId=692085e931d, content=好可惜缺乏一定的医学常识, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160613/IMG575D9886B86721544.jpg, createdBy=07961686486, createdName=1de4921fm57(暂无匿称), createdTime=Sun May 15 02:11:00 CST 2016, time=2016-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=85682, encodeId=ae01856826c, content=不作死就不会死, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=172d1721528, createdName=QQ6709219e, createdTime=Fri May 13 23:56:00 CST 2016, time=2016-05-13, status=1, ipAttribution=)]
    2016-08-08 jasonuclear

    可怕的副作用。但这些都阻止不了他们

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1828485, encodeId=28f918284856e, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Fri Mar 03 09:53:00 CST 2017, time=2017-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=106871, encodeId=ef501068e12c, content=深入学习,好文值得点赞!, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7s7ZCKOmmbBTD6nE7gcd5OZpvyGEzkxBP3S275k5ZJVrsPkotZhBglRHM9rKvcj1OgkssqhcnoPw8zIaMZTF8c/0, createdBy=4c441942088, createdName=ylzr123, createdTime=Mon Aug 29 14:21:00 CST 2016, time=2016-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=96914, encodeId=064b96914e6, content=可怕的副作用。但这些都阻止不了他们, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160515/IMG57380B859AD1F1019.jpg, createdBy=2c5c1621956, createdName=jasonuclear, createdTime=Mon Aug 08 15:46:00 CST 2016, time=2016-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1604574, encodeId=8ba116045e4e2, content=<a href='/topic/show?id=88e6941544c' target=_blank style='color:#2F92EE;'>#运动员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94154, encryptionId=88e6941544c, topicName=运动员)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c1419230799, createdName=gujh, createdTime=Sun May 15 03:53:00 CST 2016, time=2016-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=85793, encodeId=692085e931d, content=好可惜缺乏一定的医学常识, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160613/IMG575D9886B86721544.jpg, createdBy=07961686486, createdName=1de4921fm57(暂无匿称), createdTime=Sun May 15 02:11:00 CST 2016, time=2016-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=85682, encodeId=ae01856826c, content=不作死就不会死, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=172d1721528, createdName=QQ6709219e, createdTime=Fri May 13 23:56:00 CST 2016, time=2016-05-13, status=1, ipAttribution=)]
    2016-05-15 gujh
  5. [GetPortalCommentsPageByObjectIdResponse(id=1828485, encodeId=28f918284856e, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Fri Mar 03 09:53:00 CST 2017, time=2017-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=106871, encodeId=ef501068e12c, content=深入学习,好文值得点赞!, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7s7ZCKOmmbBTD6nE7gcd5OZpvyGEzkxBP3S275k5ZJVrsPkotZhBglRHM9rKvcj1OgkssqhcnoPw8zIaMZTF8c/0, createdBy=4c441942088, createdName=ylzr123, createdTime=Mon Aug 29 14:21:00 CST 2016, time=2016-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=96914, encodeId=064b96914e6, content=可怕的副作用。但这些都阻止不了他们, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160515/IMG57380B859AD1F1019.jpg, createdBy=2c5c1621956, createdName=jasonuclear, createdTime=Mon Aug 08 15:46:00 CST 2016, time=2016-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1604574, encodeId=8ba116045e4e2, content=<a href='/topic/show?id=88e6941544c' target=_blank style='color:#2F92EE;'>#运动员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94154, encryptionId=88e6941544c, topicName=运动员)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c1419230799, createdName=gujh, createdTime=Sun May 15 03:53:00 CST 2016, time=2016-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=85793, encodeId=692085e931d, content=好可惜缺乏一定的医学常识, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160613/IMG575D9886B86721544.jpg, createdBy=07961686486, createdName=1de4921fm57(暂无匿称), createdTime=Sun May 15 02:11:00 CST 2016, time=2016-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=85682, encodeId=ae01856826c, content=不作死就不会死, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=172d1721528, createdName=QQ6709219e, createdTime=Fri May 13 23:56:00 CST 2016, time=2016-05-13, status=1, ipAttribution=)]
    2016-05-15 1de4921fm57(暂无匿称)

    好可惜缺乏一定的医学常识

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1828485, encodeId=28f918284856e, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Fri Mar 03 09:53:00 CST 2017, time=2017-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=106871, encodeId=ef501068e12c, content=深入学习,好文值得点赞!, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7s7ZCKOmmbBTD6nE7gcd5OZpvyGEzkxBP3S275k5ZJVrsPkotZhBglRHM9rKvcj1OgkssqhcnoPw8zIaMZTF8c/0, createdBy=4c441942088, createdName=ylzr123, createdTime=Mon Aug 29 14:21:00 CST 2016, time=2016-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=96914, encodeId=064b96914e6, content=可怕的副作用。但这些都阻止不了他们, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160515/IMG57380B859AD1F1019.jpg, createdBy=2c5c1621956, createdName=jasonuclear, createdTime=Mon Aug 08 15:46:00 CST 2016, time=2016-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1604574, encodeId=8ba116045e4e2, content=<a href='/topic/show?id=88e6941544c' target=_blank style='color:#2F92EE;'>#运动员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94154, encryptionId=88e6941544c, topicName=运动员)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c1419230799, createdName=gujh, createdTime=Sun May 15 03:53:00 CST 2016, time=2016-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=85793, encodeId=692085e931d, content=好可惜缺乏一定的医学常识, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160613/IMG575D9886B86721544.jpg, createdBy=07961686486, createdName=1de4921fm57(暂无匿称), createdTime=Sun May 15 02:11:00 CST 2016, time=2016-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=85682, encodeId=ae01856826c, content=不作死就不会死, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=172d1721528, createdName=QQ6709219e, createdTime=Fri May 13 23:56:00 CST 2016, time=2016-05-13, status=1, ipAttribution=)]
    2016-05-13 QQ6709219e

    不作死就不会死

    0

相关资讯

NEJM:激素替代治疗可延缓早期绝经女性发生颈动脉粥样硬化

本研究旨在评估雌二醇(有或无孕激素)对颈动脉粥样硬化的影响。研究人员总共纳入643名健康的绝经女性,并根据更年期(< 6年[早期绝经后期]或≥10年[晚绝经后期])时间随机分配到两组中,一组给予17β-雌二醇1mg/日,另一组给予安慰剂。雌二醇组女性同时使用孕酮阴道凝胶,每日使用,连续10天,持续30天;安慰剂组女性以同样的用药方式使用安慰剂阴道凝胶。研究主要终点为6个月后测量女性的颈动脉内

Mucosal Immunol:激素类避孕药会增加HIV生殖道感染

全世界感染艾滋病毒的患者约有一半是女性,研究人员想鉴别出增加女性生殖器感染易感性的风险因素。 俄亥俄州立大学医学中心的研究者发现,因为艾滋病毒和其它性传播病毒必须穿透生殖器粘膜屏障才能感染,所以研究人员试图找出削弱生殖器粘膜屏障防御的因素。 他们的研究最近发表在Mucosal Immunology杂志上,文章显示用甲孕酮(DMPA)或左炔诺孕酮(LNG)治疗后显著增加了雌性小鼠生殖道病毒感

J Allergy Clin Immunol:噻托溴铵+ICS可显著改善肺功能

近期发表在J Allergy Clin Immunol的研究称,患者在吸入糖皮质激素治疗背景下,服用噻托溴铵可显著改善肺功能,尤其是接受更大剂量的患者,肺功能改善更明显。德国比勒费尔德的Eckard Hamelmann博士写道:“青少年中度哮喘患者,在吸入糖皮质激素的基础上,每日服用一次噻托溴铵[Spiriva, Boehringer Ingelheim]可显著改善肺功能,改善哮喘的控制和生活质量

J Clin Invest:性激素与骨骼健康

背景:成年男性严重缺乏性激素会导致骨质流失;然而,缺乏雄激素和雌激素对性腺功能减退的骨丢失的具体作用仍不清楚。此外,启动骨损伤的睾酮和雌二醇的阈值水平是不确定的。方法:纳入198名20-50岁健康男性,服用醋酸戈舍瑞林(抑制内源性性激素产生),随机服用每天0、1.25、2.5、5或10g睾酮凝胶,共16周。一个纳入202名男性的额外队列在这些随机治疗的基础上,服用阿那曲唑(抑制雄激素向雌激素的转化

Cell:一种新的糖尿病相关激素被发现,有望成为新靶点

研究人员一开始只是想为罹患新生儿型类早衰症(NPS)的患儿寻求答案,这种罕见遗传病会阻止机体累积脂肪,结果现在却获得了一个有可能影响数百万2型糖尿病患者生活的研究发现。他们将研究结果发布在今天的《细胞》(Cell)杂志上。 论文的资深作者、贝勒医学院医学遗传学家Atul Chopra博士,首先在2013年发现了两名罹患这种罕见疾病的患者(全世界只有少数患者被描述患有此病,且病因未知)。在

应激反应或促使癌症通过淋巴系统扩散

一项基于小鼠的研究发现,应激激素通过影响淋巴系统—— 一种在全身传输组织液的网状管道,可导致癌症扩散。研究表明针对这种应激通路的疗法或有助于阻断癌细胞扩散。相关成果近日发表于《自然—通讯》。 有证据表明应激反应和癌症患者死亡的增加以及动物晚期癌症的发展有关。此前的研究表明应激激素会影响血管形成,这在疾病扩散中很重要。淋巴系统也能促进癌症扩散,但这是否受到应激反应的影响却不清楚。 澳大利亚维多利

Baidu
map
Baidu
map
Baidu
map